As part of a regulatory review commitment to provide greater clarity, predictability, and transparency to Canada's approach to the regulation of products derived from new technologies, Health Canada has published new guidance that relates to the Novel Food Regulations (Division 28, Part B of the Food and Drug Regulations (FDR)):
- Guidance on the novelty interpretation of products of plant breeding
- Guidance on the Pre-Market Assessment of Foods Derived from Retransformants
These new guidance documents were added to the existing 2006 Guidelines for the Safety Assessment of Novel Foods as appendices.
For further information (in Portuguese), click on the Link